Statement Of Cash Flows [Abstract]
| Concept |
2021-01-01 to 2021-12-31 |
2020-01-01 to 2020-12-31 |
|---|---|---|
| Statement of cash flows [abstract] | ||
| Cash flows from (used in) operating activities [abstract] | ||
| Adjustments for finance income |
786,000
USD
|
58,000
USD
|
| Adjustments for decrease (increase) in trade and other receivables |
174,000
USD
|
2 762
USD
|
| Adjustments for impairment loss (reversal of impairment loss) recognised in profit or loss, property, plant and equipment |
227,000
USD
|
— |
| Adjustments for gains (losses) on change in fair value less costs to sell, biological assets |
8 529
USD
|
3 742
USD
|
| Adjustments for gain (loss) on disposals, property, plant and equipment |
2,000
USD
|
3,000
USD
|
| Cash flows from (used in) investing activities [abstract] | ||
| Purchase of biological assets |
18 561
USD
|
15 569
USD
|